Companies
Stay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Companies · page 2
- Press releases
Curaleaf Laboratories and Vericura Announce Distribution Agreement to Expand UK Manufacturing and Distribution of Medical Cannabis Products
Curaleaf Laboratories and Vericura today announced an agreement to strengthen the manufacturing and distribution of medical cannabis products across the United Kingdom.
- Medical Cannabis
Medical Cannabis Pioneer Bedrocan Fights to Avoid Bankruptcy in Home Market
Bedrocan, the Dutch medical cannabis stalwart thousands of patients rely on for their prescriptions, is now fighting to avoid collapse.
- Press releases
Cannabis Europa Announces Three 2027 Events, Including Flagship Move to New London Venue
Flagship London event relocates to Woolwich Works after record demand; two further European events to be revealed over the coming weeks Cannabis Europa, the international cannabis conference series from Prohibition Partners Group, today announced its 2027 event calendar: a flagship return to London, plus two further events in two other European cities — to be…
- M&A Activity
Organigram – Sanity Group Deal: What Changed and What it Means for Germany
This article was originally published in February 2026, and was most recently updated on September 22, 2026.
- Cultivation
France’s PGP Farmer Selects 5 Cannabis Strains for Future French Production as Market Nears Rollout
PGP Farmer, the French biotech building the country’s first EU-GMP medical cannabis production site, has narrowed a 30-variety Dutch phenotyping trial to five elite cultivars, laying the agronomic groundwork for its 9-hectare Dordogne facility as France closes on the reforms needed for full medical cannabis rollout.
- Press releases
Prohibition Partners Announces New Growth Marketing Platform PPX, Welcoming Heidi Whitman as its MD
Prohibition Partners pairs a decade of cannabis market infrastructure with the international network of PPX’s new Managing Director.
- Cultivation
Are We Underestimating the Pharmaceutical Potential of the Cannabis Plant?
James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation and more controlled delivery could help realise it.
- Cultivation
Inside Northern Leaf’s Remarkable Turnaround: From Brink of Collapse to £8m Cultivator
Northern Leaf, the Jersey-based medical cannabis cultivator, looked all but certain to follow in the footsteps of Curaleaf, Aurora and Tilray to become the British Isles’ very own international cannabis superstar.
- M&A Activity
Curaleaf & Aurora’s Takeover Battle: Votes, Valuations and Vitriol
Curaleaf Holdings’s takeover bid for its Canadian rival Aurora Cannabis has evolved into a public spat between the two cannabis giants over whose financial projections are honest, who would actually control the proposed new entity, and whether the current bid can even close on its own terms.
- Clinical Research
The Company That Wants to Make the Endocannabinoid System as Measurable as Blood Sugar
Dr Stefan Broselid, Founder and Scientific Lead of ECS Restore, has filed a patent application for a non-cannabinoid formulation designed to treat dysfunction in the endocannabinoid system (ECS), moving his research from scientific hypothesis towards a meaningful commercial proposition.
- Interviews
Remexian Surging Ahead One Year On From High Tide Purchase
Whilst expressing empathy with patients impacted by the recent German crackdown on cannabis flower, the head of the country’s leading wholesaler is bullish about its prospects – with orders up 50% since its purchase by Canadian cannabis giant High Tide.
- Cultivation
The Science of the Cannabis Post-Harvest Process
James Duckenfield, CEO of Glass Pharms®, explains the company’s post-harvest process, including drying and curing, and why freeze-drying is never part of it.











